Related Experiment Videos
Chronic recurrent multifocal osteomyelitis: a concise review and genetic update
Hatem I El-Shanti1, Polly J Ferguson
1Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. hatem-el-shanti@uiowa.edu
Abstract:
Chronic recurrent multifocal osteomyelitis is an autoinflammatory disorder characterized by bone pain and fever, a course of exacerbations and remissions, and a frequent association with other inflammatory conditions. Because its etiology is largely unknown, the diagnosis is still based on clinical criteria; treatment is empiric and not always successful. The diagnosis is supported by the presence of osteolytic lesions with surrounding sclerosis apparent on radiographs, and silent asymptomatic lesions frequently appear on nuclear scans. The histologic findings in bone biopsies are nonspecific, showing inflammatory changes with granulocytic infiltration. Several observations suggest the contribution of genetic factors to the etiology of chronic recurrent multifocal osteomyelitis. Indeed, mutations in LPIN2 cause a syndromic form of chronic recurrent multifocal osteomyelitis known as Majeed syndrome, while mutations in pstpip2 cause a murine form of the disorder. The roles played by LPIN2 and the human homolog of pstpip2, PSTPIP2, in the etiology of chronic recurrent multifocal osteomyelitis are uncertain but are currently being investigated. We emphasize the need to validate diagnostic clinical criteria and develop new pathogenesis-based targeted therapy.
Insights
Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory bone disorder diagnosed clinically. Research is investigating genetic factors and aiming for targeted therapies due to current treatment limitations.
Area of Science:
- Immunology
- Genetics
- Orthopedics
Background:
- Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory bone disease.
- Diagnosis relies on clinical criteria due to unknown etiology.
- Current empiric treatments are not consistently effective.
Purpose of the Study:
- To review the current understanding of CRMO.
- To highlight the need for validated diagnostic criteria.
- To emphasize the development of targeted therapies based on pathogenesis.
Main Methods:
- Review of clinical and genetic findings in CRMO.
- Analysis of diagnostic imaging (radiographs, nuclear scans).
- Histopathological examination of bone biopsies.
Main Results:
- CRMO presents with bone pain, fever, and inflammatory lesions.
- Radiographs show osteolytic lesions with sclerosis; nuclear scans detect asymptomatic lesions.
- Histology reveals nonspecific inflammatory changes.
Conclusions:
- Genetic factors, including LPIN2 and PSTPIP2 mutations, are implicated in CRMO.
- Further research is needed to validate diagnostic criteria and develop targeted treatments.
- Understanding the genetic basis is crucial for advancing CRMO therapy.
Related Concept Videos
Cryptococcal Meningitis
Bacterial Meningitis II: Pathophysiology
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Meningitis I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Infectious Diseases and Their Occurrence